La piattaforma EV costruita per il mondo reale.

Most exosome products cannot tell you what is in the vial. We can. BioThera produces extracellular vesicles at manufacturing scale, counts them by Nanoparticle Tracking Analysis, and characterizes every batch in line with MISEV2023, the consensus standard our founder helped write. One platform, one Certificate of Analysis, many applications.

Vescicola extracellulare (EV/Esosoma)

Modello strutturale in tempo reale che mostra le molecole bioattive presenti in questo sistema di consegna a nanoscala

Phospholipid bilayerSurface proteinsBiomolecular coronaIntraluminal cargoRNA molecules

Cosa fa BioThera Solutions?

BioThera Solutions is a fully integrated extracellular vesicle company working across three layers: research and intellectual property, EV manufacturing at scale, and characterization of every batch in line with MISEV2023. The same platform supplies every application built on it, and every batch leaves with its Certificate of Analysis.

EV Biomanufacturing

Scalable. Standardized. Reproducible.

Proprietary isolation and scale-up engineered for consistency: batch-level characterization, cold-chain integrity, and standardized quality control across EV sources.

Characterization & Standards

MISEV2023, by a named contributor.

Every batch is counted by Nanoparticle Tracking Analysis, screened for contaminants, and characterized against the MISEV2023 marker framework. The number on the Certificate of Analysis is a measured number, not an estimate.

Applications

One platform, several fields of use.

The same workflow supplies cosmetic applications today, while our research team investigates dermatology, tissue repair, regenerative medicine and drug delivery, with therapeutic applications an important focus. One isolation and characterization process behind all of them.

One platform. Several fields of use.

BioThera produces extracellular vesicles, characterizes them in line with MISEV2023 and documents every batch. Formulation happens downstream of that. Cosmetic applications reach the market today through an exclusive licensing partner; everything else listed here is research, and therapeutic applications are an important focus.

See the applications

Cosmetics & skincare

Our technology is licensed exclusively to Vesera™, a skincare company, for cosmetic use, and we produce the EV material it uses.

Dermatology

Research with practicing dermatologists into how characterized extracellular vesicles behave in skin.

Tissue repair & regenerative medicine

Research into the vesicle cargo associated with tissue repair and regeneration.

Drug delivery

Research into extracellular vesicles as a natural carrier for therapeutic payloads.

Made in Canada
MISEV2023 Characterization
Leaping Bunny Certified
Patent Pending
Research with Practicing Dermatologists
Made in Canada
MISEV2023 Characterization
Leaping Bunny Certified
Patent Pending
Research with Practicing Dermatologists

Building with extracellular vesicles? Start a conversation.

We work with research, clinical and industry partners. Whether you are exploring co-development, licensing or a research collaboration, reach out.

BioThera Solutions

A fully integrated extracellular vesicle company, from research and intellectual property to manufacturing at scale. Extracellular vesicles (EVs/exosomes) are among biology's most promising delivery systems, and we are building the infrastructure the field has been missing.

Ottawa, Ontario, Canada
Ottawa, Ontario Canada

© 2026 BioThera Solutions Inc. Tutti i diritti riservati.

For informational purposes only. Nothing on this website is medical advice. BioThera develops and manufactures characterized extracellular vesicles (exosomes) and, for cosmetic applications, licenses its technology exclusively to Vesera™, a skincare company. Vesera™ products are cosmetics and are not intended to diagnose, treat, cure, or prevent any disease. BioThera does not sell products to consumers, and its work on therapeutic applications is research only.